CHRISTIAN KLEIN,ERIC ELDERING,FRANK HERTING,MARINUS H.J. VAN OERS
申请号：
BR112013014522
公开号：
BR112013014522A2
申请日:
2011.12.15
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a MDM2 inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a MDM2 inhibitor.
